Home LiteratureArticle Details
PMID: 2155427 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M

Abstract

There is little information regarding the molecular mechanisms of hepatocarcinogenesis. We studied the p53 gene at the DNA, RNA, and protein level in seven human hepatocellular carcinoma (HCC)-derived cell lines; six of seven showed p53 abnormalities. By Southern blotting, the p53 gene was found to be partially deleted in Hep 3B and rearranged in SK-HEP-1 cells. Transcripts of the p53 gene were undetectable in Hep 3B as well as in FOCUS cells that had no apparent deletion or rearrangement of the p53 gene. Immunoprecipitation after [35S]methionine labeling of HCC cells demonstrated that p53 protein was absent in Hep 3B and FOCUS and reduced in concentration in PLC/PRF/5 cells. p53 synthesized by Mahlavu cells showed a slower migration on SDS/polyacrylamide gels suggesting it was an abnormal protein. In Huh7 cells, p53 protein had a prolonged half-life leading to its accumulation in the nuclei; increased levels of p53 protein were also found by immunoblotting. The p53 gene and its expression appeared to be unaltered in the hepatoblastoma-derived Hep G2 cell line. We found that the loss of p53 expression did not occur as a late in vitro event in the FOCUS cell line because p53 protein was also nondetectable at an early passage. We conclude that the loss of p53 expression or the presence of abnormal forms of the protein are frequently associated with HCC cell lines. These observations suggest that alterations in p53 may be important events in the transformation of hepatocytes to the malignant phenotype.

MeSH Terms
Blotting, Southern Carcinoma, Hepatocellular/genetics Cell Line Gene Expression Humans Liver/metabolism Liver Neoplasms/genetics Molecular Weight Nuclear Proteins/genetics Oncogene Proteins/genetics,isolation & purification Phosphoproteins/genetics,isolation & purification RNA, Neoplasm/genetics Reference Values Tumor Suppressor Protein p53
Chemicals
Nuclear Proteins Oncogene Proteins Phosphoproteins RNA, Neoplasm Tumor Suppressor Protein p53
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Bressac B
Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center, Charlestown 02129.
Galvin K M
Liang T J
Isselbacher K J
Wands J R
Ozturk M
References (45)
45 references, click to expand
  1. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
    Nature. 1984 Dec 13-19;312(5995):649-51 PMID: 6390217
  2. Identification and characterization of a Mr 50,000 adrenal protein in human hepatocellular carcinoma.
    Cancer Res. 1989 Dec 1;49(23):6764-73 PMID: 2555052
  3. Chromosomal site of hepatitis B virus (HBV) integration in a human hepatocellular carcinoma-derived cell line.
    Cytogenet Cell Genet. 1985;39(2):116-20 PMID: 2988862
  4. Precise epitope mapping of the murine transformation-associated protein, p53.
    EMBO J. 1985 Mar;4(3):699-706 PMID: 2408882
  5. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.
    EMBO J. 1985 May;4(5):1251-5 PMID: 4006916
  6. The hepatitis B virus.
    Nature. 1985 Oct 10-16;317(6037):489-95 PMID: 2995835
  7. Expression of p53 in human leukemia and lymphoma.
    Blood. 1986 Jul;68(1):113-8 PMID: 3521760
  8. Molecular cloning of an oncogene from a human hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):4993-7 PMID: 3014525
  9. Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8338-42 PMID: 3022290
  10. Characterization of the human p53 gene.
    Mol Cell Biol. 1986 May;6(5):1379-85 PMID: 2946935
  11. Molecular basis for heterogeneity of the human p53 protein.
    Mol Cell Biol. 1986 Dec;6(12):4650-6 PMID: 3025664
  12. Primary structure polymorphism at amino acid residue 72 of human p53.
    Mol Cell Biol. 1987 Feb;7(2):961-3 PMID: 3547088
  13. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma.
    Hepatology. 1987 Jul-Aug;7(4):764-72 PMID: 3038725
  14. The molecular biology of the hepatitis B viruses.
    Annu Rev Biochem. 1987;56:651-93 PMID: 3039907
  15. Identification of transforming genes as hst in DNA samples from two human hepatocellular carcinomas.
    Jpn J Cancer Res. 1987 Jul;78(7):651-4 PMID: 3040649
  16. Isolation of RNA using guanidinium salts.
    Methods Enzymol. 1987;152:219-27 PMID: 2443794
  17. Enzymes for modifying and labeling DNA and RNA.
    Methods Enzymol. 1987;152:94-110 PMID: 2443813
  18. Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region.
    J Virol. 1987 Nov;61(11):3491-8 PMID: 2822957
  19. Rearrangement of the p53 gene in human osteogenic sarcomas.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9 PMID: 2823272
  20. Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.
    J Virol. 1987 Dec;61(12):3848-54 PMID: 2824819
  21. NIH conference. Hepatocellular carcinoma.
    Ann Intern Med. 1988 Mar;108(3):390-401 PMID: 2449110
  22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  23. The influence of insulin on various enzyme activities in human and rat hepatoma cells.
    Eur J Biochem. 1976 Apr 15;64(1):249-53 PMID: 179808
  24. Hepatitis B surface antigen produced by a human hepatoma cell line.
    Br J Cancer. 1976 Nov;34(5):509-15 PMID: 187208
  25. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
    J Natl Cancer Inst. 1977 Jul;59(1):221-6 PMID: 327080
  26. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.
    J Virol. 1980 Jun;34(3):752-63 PMID: 6155477
  27. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.
    Nature. 1979 Dec 6;282(5739):615-6 PMID: 233137
  28. Integration pattern of hepatitis B virus DNA sequences in human hepatoma cell lines.
    J Virol. 1981 Jan;37(1):239-43 PMID: 6260977
  29. P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts.
    EMBO J. 1983;2(7):1041-7 PMID: 6354706
  30. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium.
    Gan. 1984 Feb;75(2):151-8 PMID: 6203805
  31. Establishment and characterization of a new human hepatocellular carcinoma cell line.
    In Vitro. 1984 Jun;20(6):493-504 PMID: 6086498
  32. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
    Nature. 1984 Dec 13-19;312(5995):646-9 PMID: 6095116
  33. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Mol Cell Biol. 1988 Feb;8(2):531-9 PMID: 2832726
  34. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma.
    J Virol. 1988 Nov;62(11):4224-31 PMID: 2845134
  35. Structural rearrangement of the retinoblastoma gene in human breast carcinoma.
    Science. 1988 Oct 14;242(4876):263-6 PMID: 3175651
  36. Meth A fibrosarcoma cells express two transforming mutant p53 species.
    Oncogene. 1988 Sep;3(3):313-21 PMID: 3060794
  37. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    J Virol. 1989 Feb;63(2):739-46 PMID: 2642977
  38. Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells.
    Oncogene. 1989 Feb;4(2):189-93 PMID: 2538792
  39. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
    Science. 1989 Apr 14;244(4901):217-21 PMID: 2649981
  40. The p53 proto-oncogene can act as a suppressor of transformation.
    Cell. 1989 Jun 30;57(7):1083-93 PMID: 2525423
  41. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
    Proc Natl Acad Sci U S A. 1989 Sep;86(17):6783-7 PMID: 2771957
  42. A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells.
    Cell. 1989 Sep 8;58(5):981-90 PMID: 2570639
  43. Wild-type p53 can inhibit oncogene-mediated focus formation.
    Proc Natl Acad Sci U S A. 1989 Nov;86(22):8763-7 PMID: 2530586
  44. p53: a frequent target for genetic abnormalities in lung cancer.
    Science. 1989 Oct 27;246(4929):491-4 PMID: 2554494
  45. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.
    Nature. 1984 Dec 13-19;312(5995):651-4 PMID: 6095117
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1990-03-00
Pages
1973-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC53607
Subset
IM
Grants
NIAAA NIH HHS · AA-01869 · United States
NIAAA NIH HHS · AA-02666 · United States
NCI NIH HHS · CA-49832 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com